Back to Search
Start Over
Plasma and Platelet Transfusion Strategies in Critically Ill Children With Malignancy, Acute Liver Failure and/or Liver Transplantation, or Sepsis: From the Transfusion and Anemia EXpertise Initiative–Control/Avoidance of Bleeding
- Source :
- Pediatr Crit Care Med
- Publication Year :
- 2022
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2022.
-
Abstract
- To present the consensus statements with supporting literature for plasma and platelet transfusions in critically ill neonates and children with malignancy, acute liver disease and/or following liver transplantation, and sepsis and/or disseminated intravascular coagulation from the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.Systematic review and consensus conference of international, multidisciplinary experts in platelet and plasma transfusion management of critically ill children.Not applicable.Critically ill neonates and children with malignancy, acute liver disease and/or following liver transplantation, and sepsis and/or disseminated intravascular coagulation.None.A panel of 13 experts developed evidence-based and, when evidence was insufficient, expert-based statements for plasma and platelet transfusions in critically ill neonates and children with malignancy, acute liver disease and/or following liver transplantation, and sepsis and/or disseminated intravascular coagulation. These statements were reviewed and ratified by the 29 Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding experts. A systematic review was conducted using MEDLINE, EMBASE, and Cochrane Library databases, from inception to December 2020. Consensus was obtained using the Research and Development/University of California, Los Angeles Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method. We developed 12 expert consensus statements.In the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding program, the current absence of evidence for use of plasma and/or platelet transfusion in critically ill children with malignancy, acute liver disease and/or following liver transplantation, and sepsis means that only expert consensus statements are possible for these areas of practice.
- Subjects :
- Evidence-Based Medicine
Critical Care
Critical Illness
Infant, Newborn
Anemia
Blood Component Transfusion
Hemorrhage
Platelet Transfusion
Disseminated Intravascular Coagulation
Liver Failure, Acute
Critical Care and Intensive Care Medicine
Article
Liver Transplantation
Plasma
Neoplasms
Sepsis
Pediatrics, Perinatology and Child Health
Humans
Child
Erythrocyte Transfusion
Subjects
Details
- ISSN :
- 15297535
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- Pediatric Critical Care Medicine
- Accession number :
- edsair.doi.dedup.....75412cb81c21f1cd78dfbdda5b77b05e
- Full Text :
- https://doi.org/10.1097/pcc.0000000000002857